Gamers to Fight Tree Ailment

A new Facebook game called Fraxinus hopes to crowdsource the solution to protecting the common ash tree from a devastating fungus.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Leaves and fruit of the common ash, Fraxinus excelsiorWIKIMEDIA, JESMOND DENE

Botanists in the UK have teamed up with game development company Team Cooper to design a social media game that uses real genetic data from the common ash tree, Fraxinus excelsior, and from the Chalara fraxinea fungus to find out what makes some trees less susceptible to it.

“The more people who play it, the more accurate the results will be for us and the quicker we can generate the information needed to help our woodlands recover from the current epidemic,” Dan MacLean, the lead botanist behind the game, called Fraxinus, said in a statement.

Chalara has wiped out between 60 percent to 90 percent of ash trees in Denmark and threatens many of the UK’s 80 million ash trees, some of which are more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Chris Palmer

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development